Skandinaviska Enskilda Banken (SEB)’s Editas Medicine EDIT Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-41,687	Closed	-$493K	–	937
2022 Q2	$493K	Sell	41,687 -4,875	-10%	-$65.3K	﹤0.01%	812
2022 Q1	$885K	Sell	46,562 -15,302	-25%	-$284K	0.01%	767
2021 Q4	$1.72M	Hold	61,864	–	–	0.01%	678
2021 Q3	$2.54M	Buy	61,864 +20,730	+50%	+$1.14M	0.01%	587
2021 Q2	$2.33M	Buy	41,134 +1,182	+3%	+$43.7K	0.01%	623
2021 Q1	$1.68M	Buy	39,952 +22,523	+129%	+$1.28M	0.01%	708
2020 Q4	$1.22M	Sell	17,429 -193	-1%	-$7.93K	0.01%	773
2020 Q3	$494K	Buy	17,622 +17,224	+4,328%	+$561K	﹤0.01%	826
2020 Q2	$12K	Buy	+398	New	+$10.4K	﹤0.01%	1036

Other funds holding EDIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s EDIT Position: Q3 2022 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Editas Medicine (EDIT) in Q3 2022, closing a stake of 41,687 shares — an estimated $493K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in EDIT in Q2 2020 and held it in 9 quarters. The position peaked at $2.54M in Q3 2021. 265 funds tracked by Wall St. Rank hold EDIT as of Q3 2022.

Skandinaviska Enskilda Banken (SEB) reported no remaining Editas Medicine position as of Q3 2022 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 41,687 Editas Medicine shares in Q3 2022, an estimated $493K.
Skandinaviska Enskilda Banken (SEB) first reported a position in Editas Medicine in Q2 2020 and held it in 9 quarters.
Skandinaviska Enskilda Banken (SEB)'s Editas Medicine position peaked at $2.54M in Q3 2021.
265 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2022.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2022, filed 14 Nov 2022.